DNB Carnegie has raised its price target for Aker Biomarine to 90 Norwegian kroner, up from the previous target of 75 kroner. The bank maintains its "hold" recommendation on the stock.
DNB Carnegie raises its price target for Aker Biomarine to 90 Norwegian kroner (previously 75), reiterating its hold rating.

















